Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

Invasive Coronary Function Testing 2024

Complex Coronary Cases

J. Sweeny

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

TCT 2024 Insights: Antiplatelet Therapy and All-Cause Mortality Afte…

TCT 2024 Insights

M. Zimarino

CRT 2025 Insights: Artificial Intelligence Based System for Identify…

CRT 2025 Insights

Y. Feld

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Emotional Toll of Complications

The Christ Hospital Heart & Vascular Institute

W. Lombardi

CT FFR Is Already the Gold Standard for Ischemia Evaluation. Here Is…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

K. Al-Azizi

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification:…

ESC 2024 Insights

A. Kini

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

ACC/AHA Guideline for Perioperative Cardiovascular Management for No…

MonteHeart Imaging & Clinical Lectures

P. Parwani

Catheters, Guidewires, and Other Devices to Achieve Technical Succes…

Jaikirshan Khatri

Intravenous ADP Antagonist: Use in High-Risk PCI and ACS

San Diego Cardiovascular Interventions Symposium 2024

E. Mahmud

Co-Registration: Do We Really Need It? - 2025 Update

ARCH Advanced Revascularization Symposium

P. Thakker